ROS implication in a new antitumor strategy based on non-thermal plasma.
Vandamme M, Robert E, Lerondel S, Sarron V, Ries D, Dozias S, Sobilo J, Gosset D, Kieda C, Legrain B, Pouvesle JM, Pape AL.
Vandamme M, et al.
Int J Cancer. 2012 May 1;130(9):2185-94. doi: 10.1002/ijc.26252. Epub 2011 Aug 12.
Int J Cancer. 2012.
PMID: 21702038